US Material Events SEC 8-K Filings — August 26, 2026

26-08-2026

Biohaven Ltd. (BHVN) entered into a strategic global licensing and collaboration agreement with SK Biopharmaceuticals for its Kv7 ion channel platform and lead candidate opakalim (BHV-7000), a Phase 2/3 Kv7.2/7.3 activator for focal epilepsy. Biohaven will receive $400 million in near-term cash ($350 million at closing plus $50 million in 2027), with potential milestone payments up to $795 million and tiered U.S. royalties (mid-teens to low twenties) plus ex-U.S. royalties. The deal provides non-dilutive capital and extends Biohaven's runway, while SK Biopharmaceuticals assumes future development costs and certain Knopp obligations; however, Biohaven forgoes direct commercialization of opakalim and retains only royalty-based upside.

• · SK Biopharmaceuticals will assume responsibility for Kv7 program costs going forward, including up to $185 million payable to Knopp Biosciences upon U.S. and EU approval plus a mid-single digit worldwide royalty.
• · SK Biopharmaceuticals will also assume up to $60 million in additional obligations for milestones related to future Kv7 pipeline programs.
• · Opakalim has been studied in more than 1,200 participants across multiple clinical trials.
• · Biohaven is conducting two Phase 2/3 randomized, double-blind, placebo-controlled studies (NCT06132893 and NCT06309966) and an open-label extension study (NCT06443463).
• · SK Life Science has a neurology field force of over 150 professionals.
• · Closing is contingent on HSR antitrust review and other customary conditions.
• · J.P. Morgan Securities LLC served as exclusive financial advisor to Biohaven; Sullivan & Cromwell LLP as legal advisor.
• · Nomura Securities International, Inc. served as exclusive financial advisor to SK Biopharmaceuticals; Paul Hastings LLP as legal counsel.

26-08-2026

Treasure Global Inc (TGL) entered into three Software Development Agreements with Malaysian and Singaporean developers to build a Lifestyle Membership and Experience Platform, with an aggregate development fee of US$3,000,000 (US$1,000,000 per agreement). Payments are milestone-based, and TGL may pay in cash or restricted common stock, with shares issued under Section 4(a)(2) and Regulation S exemptions. The agreements include termination rights, IP vesting in TGL, and indemnification clauses, but also contain liability limitations and are governed by Malaysian law.

• · Agreements have a term of three months from August 26, 2026.
• · TGL has sole discretion to pay in cash, TGL Shares, or a combination; shares issued on restricted basis for six months under Rule 144.
• · All intellectual property rights in the Software vest exclusively in TGL upon creation.
• · Developers indemnify TGL against losses including IP infringement claims.
• · Liability is limited; neither party liable for economic losses, indirect or consequential damages.
• · Confidentiality obligations survive for two years post-termination.
• · Agreements governed by Malaysian law; disputes resolved in Malaysian courts.
• · Force majeure exceeding three months allows termination without liability.
• · Shares issued under Section 4(a)(2) and Regulation S exemptions; no underwriters involved.

26-08-2026

Veea Inc. announced a 1-for-20 reverse stock split effective August 28, 2026, with post-split trading starting August 31, 2026. The split, approved by stockholders on December 30, 2025, will consolidate every 20 shares into 1 share, with fractional shares rounded up. This corporate action is typically taken to increase the per-share trading price and maintain Nasdaq listing compliance, but does not change the company's fundamental value or market capitalization.

• · Reverse stock split ratio is 1-for-20, within the range approved by stockholders on December 30, 2025.
• · Effective time: 4:30 p.m. Eastern Daylight Time on August 28, 2026.
• · Post-split trading begins at market open on August 31, 2026 under same symbol VEEA with new CUSIP 693489205.
• · Fractional shares will be rounded up to the next whole share.
• · Proportionate adjustments will be made to equity awards and outstanding warrants/convertible securities.
• · Continental Stock Transfer & Trust Co. is acting as exchange agent and transfer agent.
• · No action required for book-entry stockholders; positions held through brokers will be adjusted automatically.

26-08-2026

McEwen Inc. announced the planned retirement of COO William Shaver after 4 years with the company and over 55 years in mining, along with three senior leadership promotions to VP of Operations, VP of Development Projects, and VP of Permitting, Government Relations and Sustainability. The company highlighted progress on key projects including the Stock Mine nearing completion and El Gallo starting construction, while also noting its 46.3% stake in McEwen Copper is valued at US$456 million based on the last financing. However, the filing is primarily a personnel announcement with no financial results or operational metrics reported.

• · McEwen's 1.25% NSR on Los Azules is projected to generate approximately $584M from the initial case and $860M from the potential Nuton extension, for combined undiscounted pre-tax royalty cash flow of approximately $1.4B.
• · McEwen recently purchased 27.3% of Paragon Advanced Labs Inc., a newly listed public company deploying PhotonAssay units.
• · Rob McEwen has invested over US$290 million personally and takes a salary of $1 per year.
• · Los Azules received approval under Argentina's Large Investment Regime (RIGI), improving project economics.
• · The company's goal is to reach 250,000-300,000 GEOs by 2030.
• · William Shaver will continue to serve on the Board of Directors of McEwen Copper.
• · Channa Kumarage is a licensed Professional Engineer and Qualified Person under NI 43-101.
• · Kevin Bromfield holds a B.Sc. in Mining Engineering from Queen's University and an Executive MBA from the Ivey School of Business.
• · Zahir Jina is a certified Environmental Professional (EP), Project Management Professional (PMP) and Certified Engineering Technologist (C.E.T.).

26-08-2026

Charter Communications completed the acquisition of Cox Communications' commercial fiber and managed IT/cloud services businesses, with Cox Enterprises contributing the residential cable business to Charter. In connection with the closing, multiple supplemental indentures were executed to add Cox entities as guarantors and grant security interests, aligning the collateral and obligors across the combined capital structure on a pari passu basis. No financial figures or period-over-period comparisons are provided in this filing.

• · The Transaction Agreement was dated May 16, 2025, and the transaction closed on August 19, 2026.
• · Supplemental indentures were executed on August 24, 2026, for the CCO Indenture (Thirtieth), Cox Indenture (Twenty-Third), TWC Indenture (Eleventh), and TWCE Indenture (Twentieth).
• · The Charter Credit Agreement has been amended multiple times, most recently by Amendment No. 7 dated May 6, 2026.

26-08-2026

Key Tronic Corp (KTCC) disclosed the FY2027 incentive compensation plan and granted RSU awards to its executive officers on August 20, 2026. CEO Brett R. Larsen can earn up to 150% of base salary under the ICP, while EVPs Anthony G. Voorhees and Philip S. Hochberg can earn up to 105%. Additionally, a new long-term incentive plan for FY2027-2029 was established, with target cash awards of $400,000 for Larsen, $190,000 for Voorhees, and $150,000 for Hochberg if performance targets are met.

• · The FY2027 ICP has three performance levels: entry, expected value, and overachievement; payments are a percentage of base salary.
• · RSU awards vest over three years in equal annual installments; 40-60% of CEO RSUs and 50% of EVP RSUs are performance-based tied to annual EBITDA threshold.
• · Non-employee director RSUs (10,724 each) vest on the first anniversary of grant.
• · FY2027-2029 LTI performance measures combine sales growth compared to industry and return on invested capital; actual payments can range from $0 to 150% above target.
• · No cash awards under LTI plan if performance does not exceed minimum targets.

26-08-2026

SharonAI Holdings Inc. entered into a First Supplemental Indenture on August 21, 2026, amending the Base Indenture governing its 6.00% Convertible Senior Notes due 2031. The amendment removes certain restrictive covenants, including limitations on incurring, maintaining, and repaying indebtedness and granting liens, providing the company with greater financial flexibility. No financial figures or period-over-period comparisons are provided in this filing.

• · The First Supplemental Indenture was entered into following receipt of requisite consents from noteholders.
• · The amendment removes restrictive covenants related to indebtedness and liens.
• · The Base Indenture was originally dated May 18, 2026.
• · The Notes carry a 6.00% coupon and mature on May 1, 2031.

26-08-2026

Priority Technology Holdings, Inc. (NASDAQ: PRTH) announced the acquisition of IntelliPay, a software provider enabling government, education, and healthcare payment acceptance. The acquisition will establish a new vertical, Priority Commerce Government, expected to contribute just over $4 million of incremental revenue for the balance of 2026. The deal is a strategic expansion into the public sector, leveraging a longstanding partnership, but the near-term revenue impact is modest relative to the company's overall scale.

• · IntelliPay's software supports card and ACH payments across online, mobile, in-person, and recurring channels.
• · The acquisition is structured as a membership interest purchase agreement.
• · Priority Commerce Government is expected to contribute just over $4 million of incremental revenue for the balance of 2026.
• · The filing is an 8-K with Items 1.01 (Material Agreement Entry) and 9.01.

26-08-2026

Jasper Therapeutics, Inc. received a Nasdaq deficiency notice on August 21, 2026, for failing to meet the minimum $2.5 million stockholders' equity requirement for continued listing on the Nasdaq Capital Market. The company has 45 days (until October 5, 2026) to submit a compliance plan and intends to seek stockholder approval to convert outstanding Non-Voting Convertible Preferred Stock to regain compliance. However, there is no assurance that the plan will be accepted or that the company can ultimately maintain its listing.

• · The company's common stock (JSPR) and redeemable warrants (JSPRW) continue trading on Nasdaq with no immediate effect from the notice.
• · If the compliance plan is not accepted, or if compliance is not regained within the extension period, the company can request a hearing before Nasdaq's Hearing Panel, which would stay any delisting action pending the hearing process.
• · The company is an emerging growth company and has not elected the extended transition period for complying with new or revised financial accounting standards.

26-08-2026

21Shares Polkadot ETF filed a Certificate of Amendment to change its name to 21Shares Polkadot Staking ETF, effective upon filing. The amendment reflects a strategic shift to incorporate staking into the fund's operations, but no financial figures or performance data were disclosed.

• · The trust was originally formed under the Delaware Statutory Trust Act.
• · The name change is from '21Shares Polkadot ETF' to '21Shares Polkadot Staking ETF'.
• · The amendment was executed by CSC Delaware Trust Company as trustee.

26-08-2026

21Shares Ethereum ETF filed a Certificate of Amendment with the Delaware Secretary of State to change its name to 21Shares Ethereum Staking ETF, effective upon filing. The amendment reflects a strategic shift to incorporate staking into the fund's operations.

• · The amendment was filed under the Delaware Statutory Trust Act (12 Del. C. § 3801 et seq.).
• · The name change is from '21Shares Ethereum ETF' to '21Shares Ethereum Staking ETF'.
• · The amendment was executed by CSC Delaware Trust Company, not in its individual capacity but solely as Trustee.
• · The filing was made on August 26, 2026, and is effective immediately upon filing.

26-08-2026

21Shares Solana ETF filed an 8-K with the SEC on August 26, 2026, amending its Certificate of Trust to change its name to '21Shares Solana Staking ETF.' The amendment is effective upon filing, signaling a strategic shift toward staking activities for the ETF. No financial figures or performance data were disclosed in this filing.

• · The name change to '21Shares Solana Staking ETF' suggests the ETF may incorporate staking rewards, which could affect yield and tax treatment.
• · The amendment was executed by CSC Delaware Trust Company, acting solely as Trustee, and signed by James Grier, Associate Director.
• · The filing includes items 1.01 (Material Agreement Entry), 5.03 (Amendments to Articles of Incorporation or Bylaws), and 9.01 (Financial Statements and Exhibits).

26-08-2026

Keysight Technologies appointed Scott Reese as a Class I director effective immediately. Reese brings experience from GE Vernova's Electrification Software business and Autodesk, and will serve on the Nominating and Corporate Governance Committee and Audit and Finance Committee.

• · Scott Reese was appointed as a Class I director with term expiring in 2027.
• · He will serve on the Nominating and Corporate Governance Committee and the Audit and Finance Committee.
• · Reese previously led GE Vernova's $1.2 billion industrial software business and played a key role in GE Vernova's IPO.
• · He spent nearly two decades at Autodesk, most recently as EVP of Product Development & Manufacturing Software.
• · Reese currently serves on the boards of Planet Labs PBC, Landis+Gyr, and AutoLOTO.

26-08-2026

Ark 21Shares Bitcoin ETF (ARKB) filed an 8-K on August 26, 2026, disclosing the entry into a Second Amended and Restated Trust Agreement, which amends and restates the prior trust agreement in its entirety. The agreement updates the trust's governance, including definitions, creation/redemption procedures, and sponsor and trustee roles. No financial figures or performance metrics were disclosed in this filing.

• · The Trust was originally formed on June 22, 2021, and the prior Amended and Restated Trust Agreement was dated December 28, 2023.
• · The new agreement includes provisions for the handling of Incidental Rights, such as airdrops and hardforks, and the potential acquisition of IR Virtual Currency.
• · The Trust's Pricing Benchmark is the FTSE Bitcoin Index.
• · The Exchange for the Trust's shares is Cboe BZX Exchange, Inc.
• · The Trust's fiscal year and other operational details are defined in the agreement.

26-08-2026

Champion Homes, Inc. (NYSE: SKY) appointed Michael Haack as an independent director effective August 24, 2026, expanding the board to seven directors, six of whom are independent. Mr. Haack brings over two decades of industrial leadership experience, including his current role as President and CEO of Eagle Materials Inc., where he led over $1.6B in acquisitions. The appointment strengthens the board's manufacturing and operational expertise, though no immediate financial impact or performance changes were disclosed.

• · Michael Haack has served as President and CEO of Eagle Materials Inc. since 2019.
• · Haack spent over 17 years at Halliburton in senior manufacturing and global leadership roles.
• · Haack earned an MBA from Rice University, an MS in Industrial Engineering from Texas A&M, and a BS in Industrial Engineering from Purdue University.
• · Champion Homes has 46 manufacturing facilities across the U.S. and western Canada.
• · The company operates 95 factory-direct retail locations and Star Fleet Trucking for transportation services.

26-08-2026

21Shares XRP ETF (TOXR) filed a Fourth Amended and Restated Trust Agreement dated August 26, 2026, amending and restating the trust's governing document. The filing updates definitions, procedures for creation and redemption of baskets (10,000 shares each), and administrative details, including the appointment of CSC Delaware Trust Company as trustee and 21Shares US LLC as sponsor. No financial results or material changes in assets or performance were disclosed.

• · Trust was originally formed on June 3, 2024.
• · The trust has undergone multiple name changes and amendments, with the latest being the Fourth Amended and Restated Trust Agreement dated August 26, 2026.
• · The trust is governed by the Delaware Statutory Trust Act.
• · Shares are issued and redeemed in Baskets of 10,000 Shares.
• · The trust's XRP is held by an XRP Custodian, with a substantial portion in cold storage (Cold Vault Balance).
• · The trust's pricing benchmark is the FTSE XRP Index administered by FTSE International Limited.
• · The trust intends to be treated as a grantor trust for U.S. federal income tax purposes.
• · The trust is not registered under the Investment Company Act of 1940.

26-08-2026

21Shares Sui ETF filed a Certificate of Amendment to change its name to 21Shares Sui Staking ETF, effective upon filing. The amendment reflects a strategic shift to incorporate staking into the ETF's operations, which may enhance yield potential for investors. No financial figures or performance data were disclosed in this filing.

• · The amendment changes the trust's name from '21Shares Sui ETF' to '21Shares Sui Staking ETF'.
• · The amendment is effective upon filing with the Delaware Secretary of State.
• · The filing was made under Item 5.03 (Amendments to Articles of Incorporation or Bylaws) of Form 8-K.
• · No financial impact, revenue, or expense figures were provided in the filing.

26-08-2026

F&M Bank Corp. appointed Erica N. Truban as a director on August 25, 2026, to serve until the next annual meeting. Ms. Truban, a CPA and CISA, currently works at Intuit as Director of Customer Success – High-Value & Partner Firms. She will also join the board of the bank's wholly owned subsidiary and serve on the Audit and Operational Risk Committees. There are no reportable transactions or arrangements with Ms. Truban, and she has never been an officer or employee of the Company.

• · Ms. Truban is a Certified Public Accountant and Certified Information Systems Auditor.
• · She serves on the Audit Committee and Operational Risk Committee of the Board.
• · She will receive standard compensation for non-employee directors as described in the 2026 proxy statement.

26-08-2026

21Shares Dogecoin ETF (TDOG) filed an 8-K on August 26, 2026, announcing the entry into a Third Amended and Restated Trust Agreement, which restates the trust's governing document. The filing includes standard provisions for creation and redemption of baskets, roles of the sponsor (21Shares US LLC) and Maryland Trustee (Wilmington Trust, N.A.), and tax treatment as a grantor trust. No financial metrics or period-over-period comparisons are provided in this filing.

• · The Trust was originally formed on April 1, 2025, and the name was changed to '21Shares Dogecoin ETF' on April 7, 2025.
• · The Third Amended and Restated Trust Agreement restates the Second Amended and Restated Trust Agreement dated January 9, 2026.
• · Each Basket consists of 10,000 Shares.
• · The Trust is treated as a grantor trust for U.S. federal income tax purposes.
• · The Pricing Benchmark is the FTSE Dogecoin Index, adjusted for the Trust's expenses and other liabilities.
• · The Exchange for the Shares is the Nasdaq Stock Market LLC.

26-08-2026

Crown Reserve Acquisition Corp. I (CRACU) filed an 8-K on August 26, 2026, disclosing a First Amendment to its Business Combination Agreement with Carvix, Inc. The amendment clarifies shareholder voting thresholds for the SPAC's extraordinary general meeting and revises base salaries for certain Carvix executives, with Amir Azarpad, Ramin Farahmand, Gabriela Farahmand, and Carlos M. Hernandez receiving escalating annual salaries over three years (e.g., $500K in Year 1 to $900K in Year 3 for the top two executives). The filing does not include any financial results or performance metrics, so no positive or negative trends can be assessed.

• · The amendment clarifies that the Business Combination Proposal requires an ordinary resolution (simple majority of SPAC Ordinary Shares present and voting).
• · The Domestication Proposal and Organizational Documents Proposal each require a Special Resolution (affirmative vote of not less than two-thirds of SPAC Founder Shares present and voting), with SPAC Class A Ordinary Shares having no vote on these proposals.
• · The Director Election Proposal requires an ordinary resolution of SPAC Founder Shares only (simple majority of votes cast), with SPAC Class A Ordinary Shares having no vote.
• · The Nasdaq Proposal, Incentive Plan Proposal, and Adjournment Proposal each require an ordinary resolution (simple majority of SPAC Ordinary Shares present and voting).
• · Advisory Organizational Documents Proposals are non-binding and advisory, and their approval is not a condition to the transactions.
• · The amendment also provides that annual bonus opportunities for the named executives will be calculated as a percentage of the revised base salaries, not the amounts in the original Company Disclosure Schedule.

26-08-2026

AstroNova, Inc. (Nasdaq: ALOT) announced the completion of its acquisition by affiliates of Arcline Investment Management in an all-cash deal valued at $29.00 per share. With the closing, AstroNova will cease trading on Nasdaq and become a privately held company, with shareholders entitled to receive $29.00 in cash per share held. The transaction expands AstroNova's opportunities as a private entity, though it also marks the end of its public listing and the associated liquidity for shareholders.

• · AstroNova will cease trading and will no longer be listed on Nasdaq.
• · Shareholders will receive a letter of transmittal with instructions for surrendering stock certificates or book-entry shares.
• · Shares held in street name will receive the merger consideration through their brokerage accounts.
• · AstroNova operates in two segments: Aerospace and Product Identification.
• · Arcline is a growth-oriented private equity firm with over $30 billion in assets under management.

26-08-2026

Endovia Health Sciences, Inc. (formerly Splash Beverage Group, Inc.) entered into employment agreements with Brady Cobb as Interim CEO and Michael Bondurant as Interim COO, effective August 20, 2026. The agreements include base salaries of $300,000 and $275,000, respectively, plus performance-based cash bonuses tied to market capitalization increases, option grants, and potential RSU grants subject to shareholder approval. The filing reflects a strategic leadership change aimed at driving growth, but the compensation structure is heavily contingent on future market performance.

• · The company's name changed from Splash Beverage Group, Inc. to Endovia Health Sciences, Inc. (as indicated by the registrant name in the filing).
• · The agreements include accelerated vesting of unvested options and RSUs upon termination without cause or a change of control.
• · Executives may also earn annual performance bonuses based on revenue targets and profit goals set by management and approved by the Board or Compensation Committee.
• · The RSU grants are subject to shareholder approval and represent 7% of the 20% of fully diluted shares outstanding previously approved by the Board.
• · The company is an emerging growth company (as indicated by the check mark in the filing).

26-08-2026

Z Squared Inc. (formerly Coeptis Therapeutics Holdings, Inc.) disclosed an amendment to the employment agreement of its Chief Technology Officer, Jeffery Harris, fixing the first-year restricted stock unit award at 49,778 shares. The amendment was effective August 24, 2026, and follows a previously reported employment agreement from June 24, 2026. No financial figures or performance metrics were mentioned in the filing.

• · The amendment fixes the number of restricted stock units for Mr. Harris's first-year award at 49,778 shares.
• · The amendment was dated August 24, 2026, and filed as Exhibit 10.1.

26-08-2026

New America Acquisition I Corp. (NWAX) announced the resignation of CFO George O'Leary effective August 26, 2026, and the appointment of Tim S. Ledwick as CFO and Christopher Devall as COO. The changes are part of the company's ongoing search for a business combination targeting U.S. industrial and innovation companies. No financial metrics or performance data were disclosed in the filing.

• · George O'Leary's resignation was not due to any disagreement with the company.
• · Tim Ledwick has served as CFO of Dominari Holdings Inc. since October 2025 and previously chaired its audit committee from 2015 to 2025.
• · Christopher Devall has served as COO of Dominari Holdings since January 2023 and as CEO of SIM Acquisition Corp. I since January 2026.
• · The company is a blank-check company targeting U.S. companies in automation, advanced manufacturing, infrastructure, and energy systems.

26-08-2026

Biomerica, Inc. entered into a Securities Purchase Agreement on August 20, 2026, to issue and sell 1,393,705 shares of common stock at $1.60 per share, raising approximately $2.23 million in gross proceeds from institutional and individual investors, including B. Riley Principal Capital, LLC and certain directors and officers. The private placement closed on August 26, 2026, and the company also entered into a Registration Rights Agreement requiring it to file a resale registration statement within 30 days and use commercially reasonable efforts to have it declared effective within 30 days (or 60 days under full review), with liquidated damages of 1.0% per month (capped at 5.0%) for failures. Directors and executive officers are subject to 180-day lock-up agreements, and B. Riley Principal Capital, LLC may designate a board representative if it holds at least 10% voting power.

• · The purchase price per share was $1.60.
• · B. Riley Principal Capital, LLC may designate a board representative if it holds at least 10% voting power.
• · The lock-up agreements for directors and executive officers restrict certain transfers for 180 days following the closing.
• · The registration statement must be filed within 30 calendar days of the closing date.
• · Liquidated damages for registration failures are 1.0% of the aggregate purchase price per month, capped at 5.0% of the purchaser's subscription amount.

26-08-2026

Technology & Telecommunication Acquisition Corp filed an 8-K on August 26, 2026, disclosing the adoption of Amended & Restated Articles of Association via a special resolution passed on August 20, 2026. The amended articles govern the company's structure, including share classes (Class A, Class B, Preference Shares), IPO mechanics, trust account provisions, and business combination requirements (e.g., Fair Value ≥80% of Trust Account). The filing also includes detailed provisions for redemption events, shareholder meetings, and director powers.

• · The amended articles adopt Cayman Islands Companies Act (Revised) governance standards.
• · Class B Shares carry a 20% aggregate entitlement to all income and capital distributions.
• · Business Combination Fair Value is defined as at least 80% of Trust Account balance (excluding deferred underwriting fees and taxes).
• · Per-Share Redemption Price redemptions are calculated based on Trust Account deposits divided by outstanding Public Shares.
• · Over-Allotment Option allows underwriters to purchase up to 15% additional units at $10.00/unit.
• · Default interest rate on unpaid share calls is 10% per annum.
• · Directors may issue shares with or without special rights and fractions of shares.
• · The company may purchase its own shares and issue redeemable shares.
• · Shareholders can act by written resolution (unanimous) without a meeting.
• · Audit, Compensation, and Nominating & Corporate Governance Committees are established.

26-08-2026

CHS Inc. entered into amendments on August 26, 2026 to extend the maturity of two key financing facilities: its receivables and loans securitization facility and its repurchase financing facility, both now maturing on August 25, 2027. The amendments also implement pricing revisions, including removing the credit spread adjustment on the securitization facility. No new financial commitments or material changes to the company's overall debt profile were disclosed.

• · The securitization facility amendment (Omnibus Amendment No. 16) extends the term to August 25, 2027 and removes the credit spread adjustment.
• · The repurchase facility amendment (Omnibus Amendment No. 4) extends the scheduled term to August 25, 2027.
• · Both amendments also implement certain administrative changes.

26-08-2026

Autonomix Medical, Inc. (AMIX) entered into a warrant inducement agreement for the immediate cash exercise of July 2026 warrants for 857,462 shares at $5.75, generating approximately $4.9 million in gross proceeds. In exchange, the company issued unregistered Series E-1 and E-2 warrants to purchase 535,913 shares each at $6.25. Maxim Group LLC acted as agent.

• · The July 2026 warrants were originally issued on July 15, 2026.
• · The resale of shares from the July 2026 warrants is registered under Form S-3 (File No. 333-297760).
• · New warrants (Series E-1 and E-2) have a five-year term from issuance and are exercisable immediately.
• · The registration statement for the new warrants' underlying shares has not yet been filed.
• · Closing is expected on or about August 26, 2026.

26-08-2026

Laser Photonics Corp announced the resignation of director Carlos Gonzalez, effective August 20, 2026, with no disagreement over company operations, policies, or practices. Gonzalez had served on the Compensation, Nominating and Corporate Governance, and Audit Committees. The Board accepted his resignation.

• · Gonzalez served on three board committees: Compensation, Nominating and Corporate Governance, and Audit.
• · The resignation is described as without any disagreement on operations, policies, or practices.
• · The effective date of resignation is August 20, 2026.
• · The filing was signed by Ann Tewari, Interim President, on August 26, 2026.

26-08-2026

Extreme Networks, Inc. dismissed Grant Thornton LLP as its independent auditor and appointed Deloitte & Touche LLP, effective August 21, 2026, for the fiscal year ending June 30, 2027. The change was approved by the Audit Committee, and there were no disagreements or reportable events with Grant Thornton during the past two fiscal years or the subsequent interim period. Grant Thornton's reports for fiscal years 2025 and 2026 were unqualified.

• · Grant Thornton's reports on the consolidated financial statements for fiscal years ended June 30, 2026 and June 30, 2025 were unqualified.
• · No disagreements or reportable events occurred between the company and Grant Thornton during the two most recent fiscal years and the subsequent interim period through August 21, 2026.
• · The company did not consult Deloitte on any accounting or auditing matters prior to its appointment.

26-08-2026

AIxCrypto Holdings, Inc. elected Jason E. Dodier as an independent director on August 21, 2026, effective August 24, 2026, increasing the board size from five to six members. Mr. Dodier brings over 15 years of experience in capital markets, energy economics, and infrastructure, having most recently co-founded Grain Ecosystem Inc. through its acquisition by Mangrove Systems. The filing contains no financial results or performance metrics, only a routine board appointment.

• · Mr. Dodier's committee assignments have been deferred to a subsequent board meeting.
• · Mr. Dodier will receive compensation under the company's non-employee director compensation structure and will enter into a standard indemnification agreement.
• · Mr. Dodier holds an MBA from Georgetown University, a B.S. in Business Administration from Bryant University, and a Six Sigma Black Belt certification from Villanova University.

26-08-2026

Bleichroeder Acquisition Corp. II shareholders approved the business combination with Pasqal Holding SAS at an extraordinary general meeting on August 25, 2026. All proposals passed with strong support, including the business combination, reincorporation merger, director elections, and incentive plans. However, a significant 26,039,602 Class A ordinary shares were redeemed by public shareholders, which may reduce the cash available to the combined company.

• · All six advisory governing documents proposals were approved on a non-binding basis.
• · The Adjournment Proposal was not presented due to sufficient votes.
• · The company is an emerging growth company and has not elected to use the extended transition period for complying with new financial accounting standards.
• · The business combination includes a reincorporation merger and a French merger.
• · The combined company intends to achieve a dual listing on Euronext N.V.

26-08-2026

Gevo announced expanded executive leadership responsibilities effective August 20, 2026, to drive commercial execution, support North Dakota expansion, and advance growth plans. The company reaffirmed its outlook to deliver more than $60M in Adjusted EBITDA in 2026, while emphasizing disciplined execution and cash generation. No negative or flat metrics were disclosed in this filing.

• · Effective August 20, 2026, Greg Hanselman became COO, Kyle James became Chief Commercial and Risk Officer, and Dave Kettner added Chief Legal and Emerging Business Officer responsibilities while remaining General Counsel.
• · All three executives continue to report to CEO Paul Bloom.
• · Gevo owns and operates one of the largest dairy-based RNG facilities in the U.S. and the world's first production facility for specialty ATJ fuels (operating since 2012).
• · Gevo is developing the world's first large-scale ATJ facility co-located at its North Dakota site.
• · The company's business model includes developing, financing, and operating production facilities, with a 'pay-for-performance' approach to carbon and sustainability attributes.

26-08-2026

Leggett & Platt, Inc. filed an 8-K on August 26, 2026, announcing the adoption of Amended and Restated Articles of Incorporation. The amendments include changes to the company's name, registered agent, authorized shares (10,000 shares of common stock, par value $0.001 per share), and provisions related to director and officer indemnification and liability elimination. The filing also indicates the termination of a material agreement and changes in control, but no specific financial details or performance metrics are provided.

• · The company's registered office address is 615 S. Bishop Ave., Suite F, Rolla MO 65401.
• · The registered agent is Cogency Global Inc.
• · The corporation is formed under Missouri law (MGBCL).
• · Each holder of common stock is entitled to one vote per share.
• · Directors and officers are indemnified to the fullest extent permitted by law, with advancement of expenses subject to an undertaking.
• · Personal liability of directors for monetary damages for breach of fiduciary duty is eliminated, except for breaches of loyalty, bad faith, intentional misconduct, or improper personal benefit.

26-08-2026

Cheetah Net Supply Chain Service Inc. (CTNT) entered into an at-the-market (ATM) sales agreement with Pacific Century Securities, LLC on August 21, 2026, allowing the company to sell up to $35,280,213.01 of Class A common stock. The company will pay a 3.0% commission on gross proceeds and reimburse certain expenses. The company is not obligated to sell any shares, and the sales agent has no obligation to purchase shares on a principal basis.

• · The Sales Agreement is dated August 21, 2026, and the prospectus supplement was filed with the SEC on August 24, 2026.
• · The ATM program is based on an existing Form S-3 registration statement (No. 333-281820), filed on August 28, 2024, and declared effective on September 6, 2024.
• · The company may sell shares through the sales agent on the Nasdaq Capital Market or other trading markets, with no obligation to sell any shares.
• · The sales agent is not obligated to purchase shares on a principal basis unless otherwise agreed.
• · The company has agreed to customary indemnification and contribution rights for the sales agent and its affiliates.

26-08-2026

Starry Sea Acquisition Corp (SSEA) has entered into a definitive merger agreement with SuperiorMed Holdings Limited, a Dubai-based healthcare management and services platform focused on longevity medicine, wellness, and health tourism. The transaction will result in SuperiorMed becoming a wholly owned subsidiary of a newly formed publicly traded company. The deal is subject to shareholder and regulatory approvals, including SEC effectiveness of a registration statement and Nasdaq listing approval.

• · The Merger Agreement was signed on August 22, 2026.
• · The combined company is expected to be publicly traded on Nasdaq.
• · The transaction has been approved by the boards of directors of both SSEA and SuperiorMed.
• · Legal advisors for SuperiorMed: Loeb & Loeb LLP, Hogan Lovells International LLP, and Ogier.
• · Legal advisors for SSEA: Torres & Zheng at Law, P.C., GLA & Company Ltd, and Harney Westwood & Riegels.
• · SuperiorMed's core business includes longevity medicine, wellness services, and health tourism services through its Dubai-based operating subsidiary.

26-08-2026

CPI Card Group Inc. appointed Brennan Hughes as Chief Accounting Officer effective August 24, 2026. Hughes brings over 25 years of finance and accounting leadership, most recently as Director of Finance and Head of Investor Relations at Artisan Partners Asset Management, and previously as Senior Vice President, Chief Accounting Officer and Treasurer at Janus Henderson Group. The appointment is part of CPI's efforts to maintain financial discipline and support long-term growth.

• · Hughes holds a Master of Accountancy and a Bachelor of Science in Accounting from the University of Denver and is a Certified Public Accountant.
• · The appointment was effective August 24, 2026, two days before the filing date.
• · Hughes previously served as Senior Vice President, Chief Accounting Officer and Treasurer at Janus Henderson Group, overseeing global accounting and treasury operations.

26-08-2026

Micron Technology announced the promotion of Manish Bhatia to President and COO and Scott DeBoer to President and Chief Technology and Products Officer, effective immediately. The appointments aim to align the executive team with the company's AI-driven growth strategy. Sumit Sadana, former EVP and Chief Business Officer, has transitioned to Senior Advisor to the CEO.

• · Manish Bhatia joined Micron in 2017 and has led global operations, including manufacturing, supply chain, AI, and government affairs.
• · Scott DeBoer joined Micron in 1995 and has led the development of 15 technology nodes.
• · Sumit Sadana's new role as Senior Advisor to the CEO is effective immediately.

26-08-2026

WM announced CEO Jim Fish will retire after more than a decade in the role and over 25 years with the company, effective January 4, 2027. President John Morris has been appointed as the next President and CEO, also joining the Board. The transition is part of a robust succession plan, with the Board expressing strong confidence in Morris's leadership and track record.

• · Jim Fish has served as CEO since 2016 and will retire on Jan. 4, 2027.
• · John Morris previously held roles including Market Area GM of NYC, Area VP of Greater Mid-Atlantic, Chief Strategy Officer, SVP of Field Operations, and COO.
• · Morris is a graduate of Rutgers University.
• · The Board highlighted Morris's achievements in improving employee satisfaction, safety, and retention while reducing operating expenses.

26-08-2026

Duos Technologies Group appointed Christopher DeAlmeida as CFO effective August 24, 2026, succeeding retiring CFO Adrian Goldfarb. DeAlmeida brings over 20 years of public company financial leadership, including prior CFO roles at Wrap Technologies and Orion Group Holdings, and has completed more than 15 buy-side acquisitions. The appointment follows a comprehensive search and marks the conclusion of the company's executive transition plan.

• · DeAlmeida previously served as CFO of Wrap Technologies (Nasdaq: WRAP) from 2022 to 2024.
• · He spent 11 years with Orion Group Holdings (NYSE: ORN) as CFO, Treasurer, and Executive Vice President.
• · He is a co-founder and former CFO of a private equity-backed infrastructure platform.
• · DeAlmeida holds a Bachelor of Science in Finance from the University of Houston-Clear Lake.

26-08-2026

Saratoga Investment Corp. entered into an Eighteenth Supplemental Indenture on August 26, 2026, to issue $85 million (up to $97.75 million with underwriters' option) of 8.00% Notes due 2031. The notes bear interest at 8.00% per annum, mature on August 31, 2031, and are redeemable at the company's option on or after August 26, 2028. This debt issuance increases the company's leverage and fixed-interest obligations.

• · The Eighteenth Supplemental Indenture supplements the Base Indenture dated May 10, 2013.
• · The Notes have CUSIP number 80349A 844 and ISIN number US80349A8449.
• · Interest payment dates are February 28, May 31, August 31, and November 30, commencing November 30, 2026.
• · The notes are redeemable at 100% of principal plus accrued interest, at the company's option, on or after August 26, 2028.
• · The company may issue additional notes with the same terms if fungible for tax purposes.

26-08-2026

Somnigroup International Inc. completed its all-stock acquisition of Leggett & Platt, valued at approximately $2.3 billion. The deal strengthens Somnigroup's global platform, deepens vertical integration, and expands component engineering expertise. The company raised its annual run-rate synergy target to $75 million from an initial $50 million and reduced net leverage to approximately 2.8 times adjusted EBITDA at close. However, Somnigroup expects to incur approximately $50 million in annualized non-cash expense from fair value adjustments to the acquired business and $10 million from bond adjustments, which will impact cost of goods sold and interest expense respectively.

• · Leggett & Platt shareholders received 0.1455 shares of Somnigroup common stock per share of Leggett & Platt common stock.
• · Somnigroup expects to further reduce leverage towards the midpoint of its target range of 2.0 to 3.0 times adjusted EBITDA by year-end.
• · Leggett & Platt's financial results will be presented as a new reporting segment; sales to Somnigroup's other segments will be eliminated with no impact to reported segment profits.
• · The non-cash fair value adjustments are expected to be treated as financial adjustments under the terms of Somnigroup's credit facility.
• · The company will host a business update call on September 2, 2026 at 8:00 a.m. Eastern Time.

26-08-2026

Black Hawk Acquisition Corp. entered into a convertible note agreement with Black Hawk Management LLC for up to $300,000, intended for working capital and extension purposes. The note carries a 10% annual interest rate and is convertible into shares at $1.00 per share upon a DeSPAC transaction, or repayable in cash upon liquidation. The filing highlights the company's ongoing efforts to secure funding for its business combination, but also underscores the risks of default and the limited recourse to the trust account.

• · The note is unsecured and ranks behind trust account claims; the payee waived any claim to the trust account.
• · Drawdowns can be requested by the maker at any time before maturity, with a maximum aggregate of $300,000.
• · Events of default include failure to pay, voluntary bankruptcy, and involuntary bankruptcy with a 60-day grace period.
• · Upon a DeSPAC transaction, the payee can elect to convert the unpaid principal into unrestricted ordinary shares at $1.00 per share.
• · The conversion price is approximately one-tenth of the Class A ordinary share's initial trading price on May 13, 2024.
• · Holders of conversion shares will have registration rights similar to those in the March 20, 2024 Registration Rights Agreement.

26-08-2026

William Graves resigned from the Board of Directors and all committees of US Alliance Corporation, effective August 26, 2026, with no disagreement with the company. He forfeits all unvested restricted stock awards granted on December 11, 2024. The company will select a replacement at a future date.

• · Graves resigned from Compensation, Audit, Executive, and Nominating Committees.
• · Resignation was not due to any disagreement with the company.
• · Unvested shares from a restricted stock agreement dated December 11, 2024, are forfeited.
• · No replacement has been appointed yet.

26-08-2026

Novelis Inc. disclosed the approval of its FY2027 annual and long-term incentive plans for named executive officers, including cash and equity awards. The plans incorporate standard financial metrics (Adjusted Operating EBITDA, Cash Flow, Global Safety) and, for the CEO and CFO, additional project milestones tied to a greenfield facility in Bay Minette, Alabama. No financial figures or performance targets were disclosed in the filing.

• · The FY2027 AIP metrics for all named executive officers include Adjusted Operating EBITDA, Adjusted Operating Cash Flow, and Global Safety.
• · For the CEO and CFO, the AIP includes additional metrics tied to project milestones for the Bay Minette facility.
• · PUs vest after a three-year performance period based on return on capital employed and net income goals.
• · RSUs and SARs vest in three equal annual installments starting June 11, 2026, subject to continued employment.
• · Award agreements are substantially the same as those used for prior LTI awards.

26-08-2026

Tevogen Bio Holdings Inc. filed an 8-K on August 26, 2026, announcing a Certificate of Amendment to its Certificate of Incorporation to permit stockholder action by written consent, effective immediately. The amendment was approved by the board and stockholders, and was executed by CEO Ryan Saadi on August 25, 2026. This change enables the company to take certain actions without a formal meeting, which could streamline decision-making but also raises governance considerations.

• · The amendment was filed under Items 5.02, 5.03, 5.07, and 9.01 of the 8-K form.
• · The amendment modifies Section 7.01 of Article VII of the Certificate of Incorporation.
• · The change aligns with Section 228 of the Delaware General Corporation Law.
• · No financial figures or performance metrics were disclosed in this filing.

26-08-2026

Vireo Growth Inc. completed its acquisition of C21 Investments Inc., adding three leading Nevada dispensaries under the Silver State Relief brand and approximately 104,000 sq. ft. of cultivation and production capacity. The transaction expands Vireo's Nevada footprint to approximately 14 operational dispensaries and 159,000 sq. ft. of cultivation and manufacturing capacity. Vireo issued 2,766,409 subordinate voting shares in exchange for all outstanding C21 shares, and C21 will be delisted from the CSE and OTCQX.

• · The acquisition was effected by a court-approved plan of arrangement under the Business Corporations Act (British Columbia).
• · C21 shareholders received 0.023052 of a Vireo subordinate voting share for each C21 common share held.
• · C21 intends to cease being a reporting issuer and terminate its U.S. public reporting obligations.
• · Vireo did not own any C21 shares prior to the transaction.
• · The Vireo shares were issued in reliance on Section 3(a)(10) exemption from SEC registration.
• · C21's management information circular dated July 3, 2026, is available on SEDAR+.

26-08-2026

Universal Electronics Inc. entered into a Third Amended and Restated Credit Agreement with U.S. Bank National Association and other lenders on August 21, 2026, which revises borrowing base definitions, the consolidated fixed charge coverage ratio, and the consolidated cash flow leverage ratio. All other provisions of the prior credit agreement remain substantially the same. No financial figures or comparisons were disclosed in this filing.

• · The amendment revises borrowing base definitions, consolidated fixed charge coverage ratio covenant, and consolidated cash flow leverage ratio covenant.
• · All other provisions of the Second Amended and Restated Credit Agreement dated October 27, 2017 remain substantially the same.
• · The agreement is filed as Exhibit 10.1, with schedules omitted per SEC regulations.

26-08-2026

CuriosityStream Inc. (CURI) announced the appointment of Sean Piche, CPA, as Chief Financial Officer, effective September 1, 2026, succeeding Brady Hayden. The appointment comes on the heels of record Q2 2025 financial results, including revenue of $23.2M (up 22% YoY), record net income of $8.9M, and record adjusted EBITDA of $11.4M (up 276% YoY). The company also raised its full-year guidance for both revenue and adjusted EBITDA, signaling strong momentum.

• · Piche previously served as Partner and Global Media & Entertainment Co-Leader at CFGI and spent a decade as a Partner in EY's Financial Accounting Advisory Services practice.
• · Piche holds a Bachelor of Science in Accounting from Binghamton University and is a CPA.
• · CuriosityStream's portfolio includes 880 billion tokens of production-grade code for AI training.
• · The company operates multiple free ad-supported channels (FAST) including Curiosity Now, Curiosity History, Curiosity Animals, and Curiosity Explora.
• · The outgoing CFO Brady Hayden was thanked for his contributions.

26-08-2026

Inhibikase Therapeutics dismissed CohnReznick LLP as its independent auditor on August 21, 2026, and appointed Deloitte & Touche LLP as its new auditor for the fiscal year ending December 31, 2026. The audit reports for fiscal years 2024 and 2025 were unqualified, and there were no disagreements on accounting principles. However, CohnReznick had previously identified a material weakness in internal control over financial reporting during fiscal 2024, which was subsequently remediated.

• · The material weakness in internal control over financial reporting was first disclosed in the Q2 2024 Form 10-Q and was remediated by prior management by Q3 2024.
• · No other reportable events occurred during fiscal 2024, 2025, or the subsequent interim period through the dismissal date.
• · The Company did not consult Deloitte on any accounting, auditing, or financial reporting issues prior to their appointment.